Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Oracle Corporation’s (ORCL) U.S. Securities and Exchange Commission filings, giving investors a primary source of information on the company’s governance, capital structure, and material events. Oracle’s common stock, par value $0.01 per share, is registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ORCL, as disclosed in multiple Forms 8‑K.
Among Oracle’s key filings are current reports on Form 8‑K, which document events such as quarterly financial results, cash dividend declarations, leadership and board changes, and significant financing transactions. Recent 8‑K filings describe press releases announcing fiscal quarter results, the declaration of cash dividends on Oracle’s common stock, the promotion of executives to Chief Executive Officer roles and Principal Financial Officer, the appointment and retirement of directors, and the issuance of senior notes under an existing shelf registration statement.
Oracle’s definitive proxy statement on Schedule 14A (DEF 14A) outlines matters for its annual meeting of stockholders, including the election of directors, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The proxy statement also discusses board structure, committees, corporate governance guidelines, stock ownership policies, and executive compensation programs.
Investors may also find Form 25 filings relevant for specific Oracle debt securities. Oracle has filed a Form 25‑NSE relating to the removal from listing of its 3.125% Notes due 2025 from the New York Stock Exchange. This filing concerns a class of notes and is separate from the listing of Oracle’s common stock.
On Stock Titan, Oracle’s SEC filings are organized chronologically and can be paired with AI‑powered summaries that explain the purpose and implications of each document. This helps readers quickly understand items such as 8‑K event descriptions, proxy proposals, and capital markets transactions, while still allowing direct access to the full text of Oracle’s submissions to the SEC.
Oracle Corp (ORCL)Stephen H. Rusckowski as of 11/18/2025. He beneficially owns 60 shares of Oracle common stock directly and an additional 390 shares indirectly through the Stephen H. Rusckowski Living Trust. The filing is a Form 3, indicating his status as a new reporting director of Oracle, and does not list any derivative securities.
Oracle (ORCL) director reported insider sales. On 10/28/2025, The Berg Family Trust executed multiple sales of Oracle common stock: 9,042, 13,373, 22,724, and 4,226 shares at weighted-average prices of $281.579, $282.555, $283.627, and $284.307, respectively.
Following these transactions, 151,999 shares were beneficially owned indirectly by The Berg Family Trust, and 5,000 shares were held indirectly by the spouse.
Oracle Corp (ORCL) executive Douglas Kehring (EVP, Principal Financial Officer) reported an equity award. On 10/23/2025, he received 60,700 restricted stock units (RSUs), shown at a price of $0 as customary for awards. Each RSU represents the right to receive one share of common stock at settlement.
The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. Following this grant, 60,700 derivative securities were beneficially owned on a direct basis.
Oracle Corp (ORCL) insider Lawrence J. Ellison reported a stock option grant for 571,286 shares at an exercise price of $280.07 on October 23, 2025. The option expires on October 23, 2035 and vests 25% each year on the anniversary of the grant date. The filing lists Ellison as Director, Executive Chairman, Chief Technology Officer, and a 10% Owner, with ownership reported as Direct.
Oracle (ORCL) Form 4: Company officer Mark Hura, Pres., Global Field Operations, reported a grant of stock options on 10/23/2025. The award covers 428,465 options with an exercise price of $280.07 per share and an expiration date of 10/23/2035.
Following the grant, 428,465 derivative securities are beneficially owned, held directly. The options vest 25% each year on the anniversary of the grant date.
Oracle (ORCL) reported an insider equity award: Vice Chairman and Director Jeffrey Henley received 32,135 restricted stock units on 10/23/2025, as shown on a Form 4. Each RSU represents the right to receive one share of common stock at settlement.
The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. The filing lists the award as Direct (D) ownership.
Oracle Corp (ORCL) filed a Form 4 for CEO and Director Safra Catz detailing an equity award. On 10/23/2025, Catz was granted 32,135 restricted stock units.
Each RSU represents the right to receive one share of Oracle common stock at settlement. The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. Following the reported transaction, 32,135 derivative securities were beneficially owned, with ownership reported as direct.
Oracle Corp (ORCL) executive Maria Smith, EVP and Chief Accounting Officer, reported an equity award on a Form 4. On 10/23/2025, she was granted 35,706 restricted stock units (RSUs) (Transaction Code: A) at a price of $0.
Each RSU represents the right to receive one share of common stock at settlement. The RSUs vest in four equal annual installments, beginning on the first anniversary of the grant date. Following the reported transaction, 35,706 derivative securities were beneficially owned directly.
Oracle (ORCL): EVP and Chief Legal Officer reported equity awards. On 10/23/2025, the reporting person acquired 49,988 restricted stock units (RSUs) at a $0 price, which vest in four equal annual installments beginning on the first anniversary of the grant. The filing also records 142.94 dividend equivalents accrued on earned RSUs granted on 11/05/2022, calculated using Oracle’s closing price of $280.07 on 10/23/2025, the dividend payment date.
Following these transactions, direct derivative holdings reported were 159,157.199 after the dividend-equivalent entry and 49,988 for the new RSU grant. Each RSU represents the right to receive one share of common stock at settlement.
Oracle (ORCL) executive Maria Smith, EVP and Chief Accounting Officer, reported sales of 10,000 shares of Oracle common stock. The transactions included 5,000 shares at $280.00 on October 21, 2025 and 5,000 shares at a weighted‑average price of $280.6245 on October 23, 2025.
After these sales, she beneficially owns 47,083 shares directly. The filing notes the second trade was executed in multiple transactions within the stated price range; the weighted average price is reported.
FAQ
What is the current stock price of Oracle (ORCL)?
What is the market cap of Oracle (ORCL)?
